User talk:Danah.Albreiki

From EyeWiki

Assigned editor status

 Article statusDate reviewed
AkinetopsiaUpdate Pending14 July 2025
Balint SyndromeUp to Date14 April 2026
Calcitonin Gene-Related Peptide (CGRP) Antibodies in Neuro OphthalmologyUpdate Pending14 July 2025
Cerebral Polyopia (Cerebral Diplopia)Up to Date8 May 2026
Cerebral Visual ImpairmentUpdate Pending26 August 2025
Junctional Scotoma and Junctional Scotoma of TraquairUpdate Pending29 July 2025
Monocular Occipital Temporal Crescent SyndromeUpdate Pending19 August 2025
Multiple SclerosisUpdate Pending19 August 2025
Neuro-ophthalmic Findings in ComaUpdate Pending19 August 2025
Neuro-ophthalmic Manifestations in Adults after Childhood Periventricular LeukomalaciaUpdate Pending19 August 2025
Neuro-ophthalmic manifestations of Polyarteritis NodosaUpdate Pending19 August 2025
Neuropathy, Ataxia, Retinitis Pigmentosa (NARP) SyndromeUpdate Pending10 December 2024
Ocular Features of CraniopharyngiomaUpdate Pending10 December 2024
Ocular Manifestations of Polyneuropathy, Organomegaly, Endocrinopathy, Myeloma Protein, and Skin Changes (POEMS) SyndromeUpdate Pending8 October 2023
Ocular Manifestations of Subclavian Steal SyndromeUpdate Pending10 October 2023
Ocular TorticollisUp to Date3 April 2026
Oculogyric CrisisUpdate Pending17 March 2025
Oculomotor ApraxiaUpdate Pending10 October 2023
Ophthalmologic Manifestations in MELASUpdate Pending10 October 2023
Orbital MassesUp to Date10 May 2026
PapilledemaUpdate Pending10 December 2024
Postoperative Decompensated Strabismus Following Otherwise Uncomplicated Ocular SurgeriesUpdate Pending10 April 2025
Stellate Ganglion Block Use for Ocular ConditionsUpdate Pending10 April 2025
Stereopsis and Tests for StereopsisUpdate Pending9 December 2024
Tadpole PupilUpdate Pending9 December 2024
Tocilizumab for Management of Graves OrbitopathyUp to Date1 February 2026
Vici SyndromeUp to Date18 March 2026

Portal page

The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.